COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01022931
Recruitment Status : Completed
First Posted : December 1, 2009
Last Update Posted : December 11, 2012
Information provided by (Responsible Party):
Klara M. Pósfay Barbe, University Hospital, Geneva

Brief Summary:
This study aims to identify clinical symptoms and outcomes, as well as response to anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during the current pandemic.

Condition or disease
Healthy Immunosuppressed Asthmatic Neuromuscular Diseases

Layout table for study information
Study Type : Observational
Actual Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of a New Virus(Influenza A H1N1/09) in Children: Epidemiology, Clinical Presentation and Outcome, and Response to Treatment
Study Start Date : October 2009
Actual Primary Completion Date : February 2010
Actual Study Completion Date : July 2012

Primary Outcome Measures :
  1. ABCB1 polymorphisms [ Time Frame: 6 months ]
    ABCB1 gene polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

Biospecimen Retention:   Samples With DNA
Nasal swab; DNA for genetic polymorphisms (Response to oseltamivir)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   up to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Children seen at the emergency ward

Inclusion Criteria:

  • suspicion of H1N1 infection

Exclusion Criteria:

  • Not available for a 30 days follow-up

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01022931

Layout table for location information
Children's Hospital of Geneva, HUG
Geneva, GE, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva
Layout table for investigator information
Principal Investigator: Klara M Posfay-Barbe, MD, MS University Hospitals of Geneva
Layout table for additonal information
Responsible Party: Klara M. Pósfay Barbe, Head of Pediatric Infectious Diseases, University Hospital, Geneva Identifier: NCT01022931    
Other Study ID Numbers: H1N1epidemiology
First Posted: December 1, 2009    Key Record Dates
Last Update Posted: December 11, 2012
Last Verified: December 2012
Keywords provided by Klara M. Pósfay Barbe, University Hospital, Geneva:
Influenza A H1N1
Additional relevant MeSH terms:
Layout table for MeSH terms
Neuromuscular Diseases
Nervous System Diseases